Glazer Capital LLC’s Calidi Biotherapeutics CLDI Stock Holding History

Glazer Capital LLC’s Portfolio CLDI Stock Details CLDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,124	Closed	-$3.85M	–	215
2023 Q1	$3.85M	Buy	+3,124	New	+$3.83M	0.21%	111

Other funds holding CLDI

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

KIM LLC Wichita, Kansas $678M AUM 0.91% 1-Year Est. Return

Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

Cubist Systematic Strategies Stamford, Connecticut $7.09B AUM 21.48% 1-Year Est. Return

Bank of Montreal

Bank of Montreal Toronto, Ontario, Canada $245B AUM 31.4% 1-Year Est. Return

Elequin Capital New York $1.09B AUM 16.08% 1-Year Est. Return